Literature DB >> 12723259

Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature.

M Petrovic1, A Mariman, H Warie, M Afschrift, D Pevernagie.   

Abstract

Benzodiazepines (BZDs) constitute the most widely used symptomatic treatment of insomnia and anxiety. Many of these drugs are associated with adverse effects, such as daytime sedation and dependence with continued use. There is a concern about the rationale for and extent of benzodiazepine (BZD) use in the elderly. The sedation due to BZD use is a main risk factor for falls and other accidents. Impaired cognitive function with continuous use appears to be a major side effect. There is a general awareness that BZD use is inappropriate in many patients, and therefore discontinuation should be recommended whenever possible. Moreover, long-term use of these drugs should be actively discouraged. Although no unanimous recommendations concerning the optimal duration of the withdrawal process exist, BZDs may easily be withdrawn during a short period in most patients who are habituated to a low dose, if an initial phase with dose reduction and psychological support are provided. Alternative approaches involve sleep hygiene guidelines, behavioural treatment and psychotherapy tailored to the needs of the individual patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12723259     DOI: 10.1179/acb.2003.58.1.004

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  17 in total

1.  The use of hypnosedative drugs in a university hospital: has anything changed in 10 years?

Authors:  Annemie Somers; Hugo Robays; Kurt Audenaert; Georges Van Maele; Marc Bogaert; Mirko Petrovic
Journal:  Eur J Clin Pharmacol       Date:  2011-01-29       Impact factor: 2.953

2.  Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages.

Authors:  Jolyce Bourgeois; Monique M Elseviers; Majda Azermai; Luc Van Bortel; Mirko Petrovic; Robert R Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2011-12-22       Impact factor: 2.953

Review 3.  Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem.

Authors:  Keith D Hill; Rohan Wee
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

4.  Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.

Authors:  Jonathan R T Davidson; Douglas E Feltner; Ashish Dugar
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 5.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

6.  Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?

Authors:  Alexandra Jobert; Edouard-Jules Laforgue; Marie Grall-Bronnec; Morgane Rousselet; Morgane Péré; Pascale Jolliet; Fanny Feuillet; Caroline Victorri-Vigneau
Journal:  Eur J Clin Pharmacol       Date:  2020-10-02       Impact factor: 2.953

7.  Insomnia in general practice : a consensus report produced by sleep specialists and primary-care physicians in Italy.

Authors:  Mario Giovanni Terzano; Liborio Parrino; Enrica Bonanni; Fabio Cirignotta; Franco Ferrillo; Gian Luigi Gigli; Mariantonietta Savarese; Luigi Ferini-Strambi
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

8.  A proposal for a pharmacokinetic interaction significance classification system (PISCS) based on predicted drug exposure changes and its potential application to alert classifications in product labelling.

Authors:  Akihiro Hisaka; Makiko Kusama; Yoshiyuki Ohno; Yuichi Sugiyama; Hiroshi Suzuki
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

9.  Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder.

Authors:  Ariel Berger; Marko Mychaskiw; Ellen Dukes; John Edelsberg; Gerry Oster
Journal:  BMC Geriatr       Date:  2009-07-27       Impact factor: 3.921

10.  Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study.

Authors:  Ariel Berger; John Edelsberg; Michael Treglia; Jose Ma J Alvir; Gerry Oster
Journal:  BMC Psychiatry       Date:  2012-10-23       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.